Daiwa Securities Group Inc. - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 176 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 4.86 and the average weighting 0.1%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$48
-36.0%
15,0270.0%0.00%
Q2 2023$75
+2400.0%
15,027
+2708.8%
0.00%
Q1 2023$30.0%5350.0%0.00%
Q4 2022$3
-100.0%
5350.0%0.00%
Q3 2022$6,0000.0%5350.0%0.00%
Q2 2022$6,000
+50.0%
535
+28.6%
0.00%
Q1 2022$4,000
-33.3%
4160.0%0.00%
Q4 2021$6,000
-53.8%
416
-14.6%
0.00%
Q3 2021$13,000
+85.7%
487
+74.6%
0.00%
Q2 2021$7,000
-30.0%
2790.0%0.00%
Q1 2021$10,000
+42.9%
279
+5.7%
0.00%
Q4 2020$7,000
-76.7%
264
-66.5%
0.00%
Q3 2020$30,000
+130.8%
787
+14.4%
0.00%
Q2 2020$13,0000.0%6880.0%0.00%
Q1 2020$13,000
-27.8%
6880.0%0.00%
Q4 2019$18,0006880.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$11,310,44515.20%
Wildcat Capital Management, LLC 2,128,370$13,387,4475.11%
TPG GP A, LLC 18,716,306$117,725,5652.31%
EcoR1 Capital, LLC 4,488,200$28,230,7780.86%
Coastal Bridge Advisors, LLC 406,847$2,559,0680.73%
Kynam Capital Management, LP 396,378$2,493,2180.38%
AXQ CAPITAL, LP 73,052$459,4970.32%
Pier Capital, LLC 262,832$1,653,2130.27%
HARBOR CAPITAL ADVISORS, INC. 41,801$262,9280.26%
Woodline Partners LP 2,921,462$18,375,9960.25%
View complete list of ALLOGENE THERAPEUTICS INC shareholders